$5.13B
$13.8 Million
0.21% of portfolio
80,000
Q4 2020
New
$10.2B
$12.9 Million
0.2% of portfolio
237,851
Q1 2025
Reduced 21.72%
$5.65B
$12.8 Million
0.2% of portfolio
136,937
Q3 2025
Reduced 16.06%
$19.5B
$12.4 Million
0.19% of portfolio
23,675
Q3 2025
Reduced 0.18%
$1.19B
$12.6 Million
0.19% of portfolio
971,784
Q3 2025
Added 56.29%
$11.1B
$11.7 Million
0.18% of portfolio
50,544
Q3 2025
Reduced 0.18%
$15.3B
$10.8 Million
0.17% of portfolio
128,487
Q3 2025
Reduced 0.18%
$22.7B
$11.1 Million
0.17% of portfolio
37,018
Q3 2025
Reduced 0.18%
$10.7B
$10.4 Million
0.16% of portfolio
83,428
Q3 2024
Added 31.53%
$33.9B
$10.6 Million
0.16% of portfolio
41,946
Q3 2025
Reduced 0.18%
$1.65B
$9.45 Million
0.15% of portfolio
490,329
Q2 2025
Added 95.87%
$6.31B
$9.86 Million
0.15% of portfolio
174,936
Q3 2025
Reduced 0.18%
$70.3B
$9.69 Million
0.15% of portfolio
595,315
Q3 2025
Reduced 4.23%
$8.21B
$9.27 Million
0.14% of portfolio
126,222
Q3 2025
Reduced 0.18%
$20.5B
$7.92 Million
0.12% of portfolio
95,294
Q3 2025
Reduced 0.18%
$4.77B
$7.5 Million
0.12% of portfolio
250,000
Q4 2024
New
$2.87B
$7.02 Million
0.11% of portfolio
195,000
Q2 2025
Added 105.26%
$123B
$6.59 Million
0.1% of portfolio
9,440
Q3 2025
Added 4.1%
$3.61B
$5.81 Million
0.09% of portfolio
464,411
Q3 2025
Added 16.67%
$6.38B
$5.85 Million
0.09% of portfolio
129,031
Q3 2025
Reduced 0.18%
$1.32B
$5.35 Million
0.08% of portfolio
150,000
Q3 2025
New
$47.7B
$4.59 Million
0.07% of portfolio
9,206
Q3 2025
Added 34.57%
$152B
$3.57 Million
0.06% of portfolio
14,465
Q3 2025
Added 77.53%
$9.48B
$3.68 Million
0.06% of portfolio
44,896
Q3 2025
Added 101.53%
-
$4.21 Million
0.06% of portfolio
-
Q2 2025
New
$121B
$3.99 Million
0.06% of portfolio
5,158
Q3 2025
Added 45.87%
$92.5M
$3.16 Million
0.05% of portfolio
1,928,464
Q2 2023
Added 107.7%
$8.24B
$2.93 Million
0.05% of portfolio
69,857
Q3 2025
Added 24.82%
$4.7B
$2.91 Million
0.04% of portfolio
99,506
Q2 2025
New
$38.4B
$2.46 Million
0.04% of portfolio
7,881
Q2 2025
Added 41.52%
$54.4B
$2.86 Million
0.04% of portfolio
9,224
Q3 2025
Added 40.85%
$390M
$2.73 Million
0.04% of portfolio
1,260,000
Q2 2024
Added 18.87%
$22.8B
$2.22 Million
0.03% of portfolio
23,640
Q3 2025
Added 9.86%
$18.4B
$2.09 Million
0.03% of portfolio
23,491
Q2 2025
Added 32.78%
$14.7B
$1.4 Million
0.02% of portfolio
29,615
Q3 2025
New
$79.5B
$1.48 Million
0.02% of portfolio
11,494
Q2 2025
Reduced 99.34%
$47.1B
$975,000
0.02% of portfolio
8,717
Q3 2025
Reduced 59.1%
$9.78B
$1.37 Million
0.02% of portfolio
30,347
Q3 2025
New
$104B
$878,000
0.01% of portfolio
2,990
Q3 2025
Reduced 11.9%
-
$892,000
0.01% of portfolio
-
Q3 2025
Reduced 71.42%
$56.3B
$436,000
0.01% of portfolio
27,223
Q3 2025
Reduced 23.25%
$11.5B
$404,000
0.01% of portfolio
6,686
Q3 2025
Reduced 20.6%
$21.1B
$417,000
0.01% of portfolio
21,928
Q3 2025
Reduced 97.39%
Karyopharm Therapeutics Inc
-
$654,000
0.01% of portfolio
-
Q1 2025
New
-
$941,000
0.01% of portfolio
-
Q1 2025
New